Training Materials for Organizational Use

This module offers a 16-minute video that describes the reasons the Department of Health Care Services developed the County Touchpoints project and how it fits into other major efforts to address the state’s opioid epidemic. It also describes how the project is organized to train the targeted stakeholder groups in every county, through a regional approach.

This module offers a 25-minute video of the neuroscience of addiction as a chronic brain disease, with emphasis on Opioid Use Disorder (OUD). It describes the objectives of addiction treatment and the three types of medications approved for treating OUD – methadone, buprenorphine, and naltrexone, in laymen’s terms. Discussion questions are provided to help participants consider reactions to this information, which is new to most people.

This module offers a 29-minute video that briefly reviews the history of addiction treatment in prisons and jails and provides a variety of “cases” for treating OUD in jails, prison, courts, probation/parole, and child welfare. Considerations include recent lawsuits and finding against settings that terminate the use of MAT during incarceration or require that MAT be terminated for eligibility in justice and child welfare programs. Discussion questions and additional resources are provided to help participants translate this information into action in the workplace.

This module offers a 56-minute video that provides information, in understandable terms, about methadone, buprenorphine and naltrexone, which are the three medications approved by the Food and Drug Administration (FDA) for treatment of Opioid Use Disorder (OUD). Method of action, abuse potential, patients most appropriate for the medication, side effects, common myths, and considerations for use in jails are addressed for each medication. Duration of treatment and how medication adjustments should be made to minimize the risk of overdose are also discussed.

This module offers a 14-minute video in which stakeholders in criminal justice reflect on how they overcame skepticism about the use of MAT in jails and probation, and their experiences with using it. It includes commentary from two persons with OUD who received MAT. Supplemental materials provide evidence-based responses to the most common objections to MAT both generally and in justice settings. Discussion questions are provided to help participants translate this information into action in the workplace.

This module will take about 90 minutes to complete. It includes three components: A video created for this project in which senior leaders from adult and youth/dependency courts, probation, and child welfare agencies, public defenders, and district attorneys reflect on how their professions have changed to address addiction as a chronic brain disease and to accept and adapt to the role of Medication Assisted Treatment in treating OUD. A video “Tale of Two Inmates” that illustrates the similarities and differences that two persons with OUD experienced in the justice system, including elements which can significantly impact the likelihood of successful recovery. Workbooks specific to child welfare and various criminal justice professions about OUD and its treatment are provided. Position statements from relevant national organizations are included, as are case studies and discussions tailored to the profession. The module translates general information about treating OUD in justice settings to specific client activities and approaches that reflect current best practice.

This module offers a 26-minute video that provides general information about how benefits and coverage for treatment of all forms of Substance Use Disorders (SUD) are covered in California, and details about coverage, access to services, payment for services, and providers in your specific county.

This module offers a 57-minute panel discussion video that provides a high-level overview of current evidence-based standards of care for treating OUD in pregnant and parenting women. It addresses best practices for MAT in late pregnancy, birth, and the post-partum period, and best practices for achieving optimal outcomes for the mother’s sobriety and the newborn’s well-being. These best practices are not well integrated in many justice and human service settings. Discussion questions and additional resources are provided to help participants translate this information into action in the workplace. The session is for criminal justice and child welfare professionals who have completed earlier sessions on the neuroscience of opioid use disorder (OUD), medications for addiction treatment (MAT), and their professional association positions regarding the need to make all FDA-approved MAT medications available to persons with OUD.

The module is for criminal justice and child welfare professionals who have completed earlier sessions on the neuroscience of Opioid Use Disorder (OUD), medications for addiction treatment (MAT), and their professional association positions regarding the need to make all FDA-approved MAT medications available to persons with OUD. This 63-minute video provides information on toxicology testing as part of treatment of OUD, and evidence-based considerations for interpreting toxicology results in the context of court-ordered treatment and conditions of probation/parole or dependency determinations. Content addresses use of other illicit substances during OUD treatment, the expected trajectory of relapse within recovery, and more. Discussion questions and additional resources are provided to help participants translate this information into action in the workplace.